- Zacks•6 hours ago
Merrimack (MACK) reported a fourth-quarter loss in-line with the estimates.
- Associated Press•7 hours ago
The Cambridge, Massachusetts-based company said it had a loss of 25 cents per share. The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research ...
- PR Newswire•7 hours ago
CAMBRIDGE, Mass., March 1, 2017 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) today announced its fourth quarter and full year 2016 financial results for the period ended December 31, ...
MACK : Summary for Merrimack Pharmaceuticals, Inc. - Yahoo Finance
Merrimack Pharmaceuticals, Inc. (MACK)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Bid||3.01 x 3700|
|Ask||3.02 x 5500|
|Day's Range||2.90 - 3.15|
|52 Week Range||2.83 - 9.02|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-2.19|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|